Sustainable innovation, transparency and managing the relationship with consumers are just some of the challenges facing the health industry as it seeks to strengthen its reputation.
Health is one of the most important growth motors of developed economies.
Today we are immersed in a progressive ageing process of the population at the same time as the levels of demand of citizenry regarding the services and care received increases. In addition, the regulatory changes and cutbacks in budget are factors that determine a sector marked by its complexity, in which the different agents involved – patients, health professionals, stakeholders, etc. – demand different needs for information that must be met.
Medical products and pharmaceutical companies that are faced with a constant process of scrutiny and regulation by the governments, require good managers that have in-depth knowledge of the new scenario to administer them. The enterprises in the sector are consequently committed to innovation as a means for searching for efficiency and differentiation. This commitment must be combined with social projects that imply a long-term benefit to society.
An innovation that must go hand in hand with a good reputation in an ever more transparent scenario and where information flows free of any barriers. The importance to focus on transparency is furthermore increased, if it is considered that health professionals, health managers and citizenry, as a whole, have an increasingly keener influence in decision making in health policies.
Our multidisciplinary team of consultants, who count on extensive experience in the sector, coordinates strategic communication plans for launching new awareness campaigns and new products, for example, for the purpose of consolidating an involvement with the scientific community and patients’ associations to finally establish a two-way dialogue with all the stakeholders, based on trust.
Today we are immersed in a progressive ageing process of the population at the same time as the levels of demand of citizenry regarding the services and care received increases. In addition, the regulatory changes and cutbacks in budget are factors that determine a sector marked by its complexity, in which the different agents involved – patients, health professionals, stakeholders, etc. – demand different needs for information that must be met.
Medical products and pharmaceutical companies that are faced with a constant process of scrutiny and regulation by the governments, require good managers that have in-depth knowledge of the new scenario to administer them. The enterprises in the sector are consequently committed to innovation as a means for searching for efficiency and differentiation. This commitment must be combined with social projects that imply a long-term benefit to society.
An innovation that must go hand in hand with a good reputation in an ever more transparent scenario and where information flows free of any barriers. The importance to focus on transparency is furthermore increased, if it is considered that health professionals, health managers and citizenry, as a whole, have an increasingly keener influence in decision making in health policies.
Our multidisciplinary team of consultants, who count on extensive experience in the sector, coordinates strategic communication plans for launching new awareness campaigns and new products, for example, for the purpose of consolidating an involvement with the scientific community and patients’ associations to finally establish a two-way dialogue with all the stakeholders, based on trust.
The Healthcare Sector and the Future of Pharmaceutical Companies
Cases
Multiópticas
Novartis
21 May 2020
Family Businesses: turning point and way out of the COVID...
Family businesses are an essential part of the economy; not only because they account for more than 90% of all companies worldwide and provide 70% of all jobs in...
5 May 2020
The role of CEOs in anticipating recovery
Two weeks ago, I shared some thoughts on what senior executives can do to stop the economic hemorrhage brought about by the COVID-19 crisis and the keys to...
30 Apr 2020
Corporate strategies for private capital incursions
Corporate strategies for private capital incursions M&A and share activism in the post-Covid 19 era and a beleaguered stock market In the current en...
28 Apr 2020
Latin America Current Report: Three expert views of the p...
As we transitioned into 2020, most global experts and political scientists were raising concerns that suggested Latin America was facing one of its regular periods of difficulty. Numerous theories...